Loading provider…
Loading provider…
Hematology & Oncology Physician in Jacksonville, FL
NPI: 1386876928Primary Practice Location
MAYO CLINIC
4500 San Pablo Rd S, Jacksonville, FL
Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Pooja's Phone NumberMobile
Get MD Pooja's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2012 - 2026
GA State Medical License
2024 - 2025

American Board of Internal Medicine
Medical Oncology
University at Buffalo
Residency • Internal Medicine
2009 - 2012
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
2012 - 2015
Dr. DY Patil Medical College
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 173 | 279 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 47 | 47 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 30 |
| 4 | 99211Established patient office or other outpatient visit, typically 5 minutes | 11 | 13 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 11 | 11 |
Authors: James Foran, Radhika Ghosh, Gerardo Colon-Otero, Sikander Ailawadhi, Abhisek Swaika, Vivek Roy, Asher Chanan-Khan
Journal: Cancer
Publication Date: 2015-11-13
Authors: Anthony Jaslowski, Timothy Hobday, Edith Perez, Alvaro Moreno-Aspitia, Jennifer Crozier
Journal: Clin Breast Cancer
Publication Date: 2015-08-19
Lead Sponsor: Sermonix Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Fulvestrant in combination with abemaciclib, DRUG: Lasofoxifene in combination with abemaciclib
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Intervention / Treatment: DRUG: Placebo, DRUG: Trastuzumab, DRUG: Pertuzumab, DRUG: Tucatinib, DRUG: Combination product: Trastuzumab + Pertuzumab
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Questionnaire Administration, DEVICE: Medical Device Usage and Evaluation